Bupropion as a Treatment for Sexual Dysfunction Among Chronic Kidney Disease Patients
,
Abstract
Sexual dysfunction is a common complication among male patients with chronic kidney disease. Common disturbances include erectile dysfunction, decreased libido, and infertility. Sexual dysfunction is a multifactorial problem, and the treatment options are limited, it associated with lower quality of life scores in patients. Chronic kidney disease also has a critically impairing effect on the quality of life. To investigate the efficacy of bupropion on sexual dysfunction and quality of life in men with chronic kidney disease, a single-blind placebo-controlled trial was conducted. A total of 40 male patients with chronic kidney disease suffering from erectile dysfunction (Mean age 41/25±8/8) were randomly assigned to receive 10 weeks of treatment with either bupropion or placebo. Sexual function and quality of life were assessed by IIEF5 and WHOQOL-BREF questionnaires, respectively. Baseline demographic and clinical features were similar in both groups. The results showed a significant difference between the intervention and control groups in sexual function (P=0/005) and total quality of life (P=0/001); also the difference was significant in physical health (P=0/012), psychological health (P<0/001) and social relationship (P<0/001) domains. Our findings suggest that Bupropion is effective and safe for treating sexual dysfunction in men with chronic kidney disease and also could positively affect the quality of life among the patients.
Kandeel FR, Koussa VK, Swerdloff RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev. 2001;22(3):342-88. Epub 2001/06/16.
Neto AF, de Freitas Rodrigues MA, Saraiva Fittipaldi JA, Moreira ED, Jr. The epidemiology of erectile dysfunction and its correlates in men with chronic renal failure on hemodialysis in Londrina, southern Brazil. International journal of impotence research. 2002;14 Suppl 2:S19-26. Epub 2002/08/06.
Carson CC, Burnett AL, Levine LA, Nehra A. The efficacy of sildenafil citrate (Viagra) in clinical populations: an update. Urology. 2002;60(2 Suppl 2):12-27. Epub 2002/11/05.
Rosas SE, Joffe M, Franklin E, Strom BL, Kotzker W, Brensinger C, et al. Association of decreased quality of life and erectile dysfunction in hemodialysis patients. Kidney Int. 2003;64(1):232-8. Epub 2003/06/06.
Wagner G, Fugl-Meyer KS, Fugl-Meyer AR. Impact of erectile dysfunction on quality of life: patient and partner perspectives. International journal of impotence research. 2000;12 Suppl 4:S144-6. Epub 2000/10/18.
Antonucci M, Palermo G, Recupero SM, Bientinesi R, Presicce F, Foschi N, et al. Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 2016;87(4):299-305. Epub 2016/01/15.
Suzuki E, Nishimatsu H, Oba S, Takahashi M, Homma Y. Chronic kidney disease and erectile dysfunction. World journal of nephrology. 2014;3(4):220-9. Epub 2014/11/07.
Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Querques M, et al. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clinical journal of the American Society of Nephrology : CJASN. 2010;5(6):985-95. Epub 2010/05/26.
Anantharaman P, Schmidt RJ. Sexual function in chronic kidney disease. Advances in chronic kidney disease. 2007;14(2):119-25. Epub 2007/03/31.
Soykan A, Boztas H, Kutlay S, Ince E, Nergizoglu G, Dilekoz AY, et al. Do sexual dysfunctions get better during dialysis? Results of a six-month prospective follow-up study from Turkey. International journal of impotence research. 2005;17(4):359-63. Epub 2005/04/15.
Chunder R. Sexual dysfunction: an approach for the pharmacist: review. SA Pharmaceutical Journal. 2011;78(9):18-21.
Seibel I, Poli De Figueiredo CE, Teloken C, Moraes JF. Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction. J Am Soc Nephrol. 2002;13(11):2770-5. Epub 2002/10/25.
Turk S, Solak Y, Kan S, Atalay H, Kilinc M, Agca E, et al. Effects of sildenafil and vardenafil on erectile dysfunction and health-related quality of life in haemodialysis patients: a prospective randomized crossover study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2010;25(11):3729-33. Epub 2010/05/15.
Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Saglimbene V, et al. Interventions for treating sexual dysfunction in patients with chronic kidney disease. The Cochrane database of systematic reviews. 2010(12):CD007747. Epub 2010/12/15.
Ginzburg R, Wong Y, Fader JS. Effect of bupropion on sexual dysfunction. Ann Pharmacother. 2005;39(12):2096-9. Epub 2005/11/17.
Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor. Prim Care Companion J Clin Psychiatry. 2004;6(4):159-66. Epub 2004/09/14.
Pakpour AH, Zeidi IM, Yekaninejad MS, Burri A. Validation of a translated and culturally adapted Iranian version of the International Index of Erectile Function. Journal of sex & marital therapy. 2014;40(6):541-51.
Nedjat S, Naieni KH, Mohammad K, Majdzadeh R, Montazeri A. Quality of life among an Iranian general population sample using the World Health Organization’s quality of life instrument (WHOQOL-BREF). International journal of public health. 2011;56(1):55-61.
Safarinejad MR. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study. BJU international. 2010;106(6):840-7. Epub 2010/01/14.
Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. The Journal of clinical psychiatry. 2004;65(1):62-7.
Gitlin MJ, Suri R, Altshuler L, Zuckerbrow-Miller J, Fairbanks L. Bupropion-sustained release as a treatment for SSRI-induced sexual side effects. Journal of sex & marital therapy. 2002;28(2):131-8. Epub 2002/03/16.
Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K. Strategies for managing sexual dysfunction induced by antidepressant medication. The Cochrane database of systematic reviews. 2013(5):CD003382. Epub 2013/06/04.
Modell JG, May RS, Katholi CR. Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study. Journal of sex & marital therapy. 2000;26(3):231-40. Epub 2000/08/10.
Peng YS, Chiang CK, Hung KY, Chiang SS, Lu CS, Yang CS, et al. The association of higher depressive symptoms and sexual dysfunction in male haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2007;22(3):857-61. Epub 2006/11/24.
Bellinghieri G, Santoro D, Mallamace A, Savica V. Sexual dysfunction in chronic renal failure. Journal of nephrology. 2008;21 Suppl 13:S113-7. Epub 2008/07/02.
Kimmel PL, Patel SS, editors. Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Seminars in nephrology; 2006: Elsevier.
Pourmand G, Emamzadeh A, Moosavi S, Mehrsai A, Taherimahmoudi M, Nikoobakht M, et al. Does renal transplantation improve erectile dysfunction in hemodialysed patients? What is the role of associated factors? Transplantation proceedings. 2007;39(4):1029-32. Epub 2007/05/26.
Sayuk GS, Gott BM, Nix BD, Lustman PJ. Improvement in sexual functioning in patients with type 2 diabetes and depression treated with bupropion. Diabetes care. 2011;34(2):332-4. Epub 2011/01/29.
Lew SQ, Piraino B. Quality of life and psychological issues in peritoneal dialysis patients. Seminars in dialysis. 2005;18(2):119-23. Epub 2005/03/18.
Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS medicine. 2012;9(9):e1001307. Epub 2012/09/18.
Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. AM J Kidney Dis. 1997;29(4):584-92. Epub 1997/04/01.
Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. Journal of the American Society of Nephrology. 2001;12(12):2797-806.
| Files | ||
| Issue | Vol 57, No 5 (2019) | |
| Section | Articles | |
| DOI | https://doi.org/10.18502/acta.v57i5.1869 | |
| Keywords | ||
| Chronic kidney disease Bupropion Sexual dysfunction Quality of life | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
